VANCOUVER, BC / ACCESSWIRE / June 20, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that it is launching new genetic cancer tests to help
VANCOUVER, BC / ACCESSWIRE / June 16, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that following its application for registration with
Aligns With Company's Substantial U.K. Presence and Supports Its Growth StrategyRedomicile to GuernseyVANCOUVER, BC / ACCESSWIRE / June 10, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody"
VANCOUVER, BC / ACCESSWIRE / May 26, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that, it has launched its core UK Health check which